EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement?

scientific article published on 6 September 2012

EBV reactivation serological profile in primary Sjögren’s syndrome: an underlying trigger of active articular involvement? is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1010936447
P356DOI10.1007/S00296-012-2504-3
P698PubMed publication ID22955798

P50authorEloisa BonfaQ37837127
P2093author name stringSandra Gofinet Pasoto
Cleonice Bueno
Elaine Pires Leon
Henrique Pires Chakkour
Margarete Borges Gualhardo Vendramini
Mauricio Levy Neto
Renato Romera Natalino
Vilma Dos Santos Trindade Viana
P2860cites workChanges in Epstein-Barr virus antibody titers associated with agingQ45838703
Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndromeQ45841151
Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndromeQ45855334
Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjögren's syndrome and other diseases of the oral cavity.Q55239951
Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndromeQ56907597
Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primersQ58004106
Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisalQ69928846
Rheumatic disease patients, prone to Sjögren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2Q71843616
Adequate sampling in cryoglobulinaemia: recommended warmlyQ73124369
Sjögren's syndromeQ79911823
Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndromeQ80367281
Association of Epstein-Barr virus with systemic lupus erythematosus - effect modification by race, age, and cytotoxic T lymphocyte-associate antigen 4 genotypeQ23911107
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Q28292418
Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassayQ30775402
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicryQ33364289
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosusQ33993288
Epstein-Barr virus induces erosive arthritis in humanized miceQ34058760
Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from BrazilQ34114546
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeQ34117422
Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expressionQ34126659
Role of viruses in systemic lupus erythematosus and Sjögren syndromeQ34404100
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupQ34523084
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasiasQ34723026
Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patientsQ34778403
Epstein-Barr virus in autoimmune diseasesQ34887020
Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.Q34981036
Epstein-Barr virus-recent advancesQ35076846
The curiously suspicious: a role for Epstein-Barr virus in lupusQ36677016
Sjögren's syndrome--study of autoantigens and autoantibodiesQ36997269
Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumorsQ38893630
Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.Q39452552
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.Q39517698
Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomasQ40491223
Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patientsQ41201388
Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndromeQ41338909
Comparison of commercial ELISA for detection of antibodies to the viral capsid antigen (VCA) of Epstein-Barr virus (EBV).Q41745057
Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" PatternQ41854842
Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndromeQ44220706
Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.Q45374201
Prevalence of Epstein-Barr virus reactivation in pregnancyQ45376840
Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus diseaseQ45381481
Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2.Q45399452
Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 yearsQ45773968
Sex difference in the serostatus of adults to the Epstein-Barr virusQ45781989
P433issue5
P304page(s)1149-1157
P577publication date2012-09-06
P1433published inRheumatology InternationalQ15763689
P1476titleEBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
P478volume33